Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 10.8K | $3.42M | $316.92 | Nov 21, 2024 | Direct |
MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Officer | Market Stock Unit | 3.64K | $888K | $243.92 | Jan 23, 2024 | Direct |
MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Officer | Stock Option (Right to Buy) | 5.48K | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 21, 2024 | 1 | -$218K | 4 | Nov 22, 2024 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Jan 23, 2024 | 3 | $0 | 4 | Jan 25, 2024 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 20, 2023 | 2 | $0 | 4 | Nov 22, 2023 | Chief Commercial Officer |
MDGL | MADRIGAL PHARMACEUTICALS, INC. | Nov 20, 2023 | 0 | $0 | 3 | Nov 22, 2023 | Chief Commercial Officer |